세계의 불임 치료 서비스 시장 보고서(2025년)
Fertility Services Global Market Report 2025
상품코드 : 1824497
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,444,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,314,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,184,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

불임 치료 서비스 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 연평균 복합 성장률(CAGR) 13.7%로 성장할 전망이며, 1,236억 달러로 성장이 예측됩니다. 예측 기간의 성장은 불임률 상승, 불임 치료 기술 개발, 임신을 돕는 불임 치료 서비스 채용 확대, 정부 이니셔티브 증가, 가처분소득 상승, 만혼화 경향 증가로 인한 것으로 예측됩니다. 예측 기간 주요 동향으로는 불임 치료 서비스에서의 인공지능에 대한 주목, 기술의 진보, 이수성 스크리닝을 위한 착상전 유전학적 검사(PGT-a), DNA 단편화 지수(DFI), 블록체인을 이용한 불임 치료 서비스 앱, 체외 수정(IVF) 서비스에서의 IoT(사물인터넷), 전략적 파트너십, M&A 등을 들 수 있습니다.

향후 5년간의 성장률 13.7%라고 하는 예측은 전회 예측으로부터 0.1%라고 하는 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 관세 장벽은 일본과 스웨덴에서 공급되는 체외수정(IVF)용 배양기 및 유리고화 시스템의 비용을 상승시켜 치료 성공률을 저하시키고 불임 치료 클리닉의 운영 비용을 상승시킴으로써 미국을 저해할 것으로 예측됩니다. 또한 상호관세와 무역 긴장 증가 및 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더욱 광범위해질 것으로 보입니다.

예상되는 불임률의 상승은 예측 기간 동안 불임 치료 서비스 수요 증가를 견인할 것으로 보입니다. 비만, 스트레스, 우울증, 알코올의 대량 섭취 등 라이프 스타일의 변화와 관련된 다양한 요인이 불임률의 상승에 기여하고 있으며, 불임 치료 서비스에 대한 요구가 높아지고 있습니다. 그 예로, 2023년 4월에 세계보건기구(WHO)가 발표한 보고서는 세계 수백만 명의 생식 연령에 있는 사람들이 불임의 과제에 직면하여 개인뿐만 아니라 가족과 지역사회에도 영향을 미칠 것으로 예상되고 있다고 강조하고 있습니다. 전 세계에서는 성인 6명 중 1명, 즉 성인 인구의 약 17.5%가 불임으로 고민할 것으로 예측됩니다. 따라서 불임률의 급증은 시장에서 불임 치료 서비스 수요에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Fertility treatment refers to a medical intervention aimed at enhancing the likelihood of conceiving a child, with the objective of increasing the chances of successful childbirth.

Within fertility services, various types are available, including fresh non-donor services, frozen non-donor services, egg and embryo banking, fresh donor services, and frozen donor services. In the context of fresh donor egg in vitro fertilization (IVF) cycles, donor eggs are promptly fertilized with the sperm from the male partner, and the resulting fresh embryos are transferred to the recipient. Any remaining embryos can be preserved for potential use in subsequent frozen embryo transfers. Assisted reproductive technology (ART), in-vitro fertilization, and artificial insemination are among the diverse procedures employed in fertility services, catering to both male and female individuals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The fertility services market research report is one of a series of new reports from The Business Research Company that provides fertility services market statistics, including fertility services industry global market size, regional shares, competitors with a fertility services market share, detailed fertility services market segments, market trends and opportunities, and any further data you may need to thrive in the fertility services industry. This fertility services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fertility services market size has grown rapidly in recent years. It will grow from $64.16 billion in 2024 to $73.96 billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to high prevalence of pcos (polycystic ovary syndrome), the increasing cases of premature ovarian failure, the rise in male infertility, insurance providers offering coverage for IVF (in vitro fertilization) procedures and the increase in same-sex couples.

The fertility services market size is expected to see rapid growth in the next few years. It will grow to $123.6 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to the rising infertility rate, technological developments in fertility treatment, the growing adoption of fertility services to aid in pregnancy, the increasing government initiatives, the rise in disposable income and the growing trend of late parenthood. Major trends in the forecast period include focus on artificial intelligence in fertility services, technological advancements, preimplantation genetic testing for aneuploidy screening (PGT-a), DNA fragmentation index (DFI), blockchain-based fertility service apps, IoT (internet of things) in in-vitro fertilization services, strategic partnerships and mergers and acquisitions.

The forecast of 13.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of IVF incubators and vitrification systems sourced from Japan and Sweden, thereby reducing treatment success rates and elevating fertility clinic operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expected rise in infertility rates is set to drive increased demand for fertility services in the forecast period. Various factors related to lifestyle changes, such as obesity, stress or depression, and high alcohol consumption, contribute to the increasing rates of infertility, creating a heightened need for fertility services. As an example, a report from the World Health Organization (WHO) in April 2023 highlighted that millions of individuals worldwide of reproductive age are expected to face challenges with infertility, affecting not only individuals but also families and communities. Globally, an estimated 1 in 6 adults, or approximately 17.5% of the adult population, is projected to grapple with infertility. Thus, the surge in infertility rates is poised to fuel the demand for fertility services in the market.

The anticipated growth of the fertility services market is further driven by the increasing prevalence of Polycystic Ovary Syndrome (PCOS). PCOS, a common hormonal disorder affecting individuals with ovaries during their reproductive years, is on the rise, leading to a higher demand for fertility services such as in-vitro fertilization (IVF) and other assisted reproductive techniques. For example, as of June 2023, the World Health Organization reported that approximately 8-13% of women in their reproductive years are estimated to be affected by PCOS, and a significant portion, as high as 70%, remains undiagnosed globally. Consequently, the growing prevalence of PCOS contributes to the upward trajectory of the fertility services market.

Companies in the fertility services market have observed notable growth in research collaborations and approvals for research funding. Key market players are expected to increase their investment in Research and Development (R&D) to introduce advanced techniques and drugs for fertility treatments. For example, in October 2022, Maven Clinic, a US-based company specializing in telemedicine-based virtual clinics for women's and family health, collaborated with Indira IVF, an India-based infertility specialty clinic chain. The collaboration aimed to provide Maven members in India access to high-quality clinical care, additional benefits, and top-notch virtual family-building care through the Maven platform. Additionally, in February 2021, CooperSurgical, a US-based women's healthcare solutions company, partnered with Virtus Health, an Australia-based fertility services provider. The collaboration focused on digitalization, cryogenics, and reproductive genetics, with initiatives aimed at supporting patients' fertility journeys, including those requiring egg, sperm, or embryo donations.

Major companies in the fertility services market are actively innovating new technologies to optimize In Vitro Fertilization (IVF) procedures and maintain a competitive edge. IVF is a medical procedure that involves combining eggs and sperm outside the body to create embryos, which are then implanted in the uterus to facilitate pregnancy for individuals or couples facing fertility challenges. For example, in October 2022, Alife Health, a US-based medical equipment manufacturing company, launched the Alife Assist platform. This suite of products aims to revolutionize the IVF process by leveraging data-driven insights and artificial intelligence (AI) to support clinical decision-making during crucial IVF stages and streamline fertility clinic operations. The platform includes Stim Assist, Embryo Assist, and Insights, offering comprehensive support to reproductive endocrinologists, embryologists, and clinic administrators, thereby enhancing medication dosing, embryo grading, and real-time performance monitoring to improve the overall patient experience and success rates in IVF procedures.

In November 2023, IVI RMA, a Spain-based company specializing in assisted reproduction technology (ART), acquired the North American operations of Eugin Group. This strategic acquisition strengthens IVI RMA's market leadership in North America and underscores the company's commitment to delivering evidence-based fertility solutions that maximize success for a wide range of patients. Eugin Group is also a Spain-based provider of fertility services.

Major companies operating in the fertility services market include Vitrolife, Merck KGaA, Progyny Inc., Virtus Health, Medicover Group, Apollo Hospitals Enterprise Ltd., Integramed America, Inc., The Johns Hopkins Health System Corp, Care Fertility, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bloom Fertility Center, Center for Advanced Reproductive Medicine and Infertility, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, KL Fertility & Gynecology Centre, LIFE - Lahore Institute of Fertility & Endocrinology, Maria Fertility Hospital, Morula IVF, Nepal International Fertility Centre, Repromed, SAFE Fertility Center, Southend Fertility and IVF, Thomson Medical Pte Ltd, TMC Fertility Centre, Victory A.R.T. Laboratory Phils. Inc, Virtus Health, CHA Fertility Center, United Family Hospital, The New Hope Fertility Center, NOVA IVF Fertility, Baby Joy Fertility and IVF, Fortis La Femme, ART Fertility Clinics, Ferticity Fertility Clinic, Milann Fertility Centre, Fertility First, City Fertility Sydney, Westmead Fertility Centre, Demeter Fertility, Adora Fertility, Rainbow Fertility, Monash IVF Group Limited, Mitra Keluarga Karyasehat Tbk PT, Sarang-i IVF Center, Beyond IVF, Bumrungrad International Hospital, Superior A.R.T, King's Fertility, Manchester Fertility, St Roch IVF Center, Clinique De La Muette, Institut Marques, Hopital Cochin, iTrust Fertility, Apricity, Agora Clinic, TFP Fertility, Apryl, CCRM Fertility Clinic, ORIGIO, Maven Clinic, Bayonne Centre, Biomedival, Grand Paris Fertility Centre, Ava-Peter Clinic, IVF Russia (The International Centre Of The Reproductive Medicines), Next Generation Clinic, Scandinavia AVA-Peter, Nova Vita Clinic, INVICTA Fertility Clinics, Gyncentrum Fertility Clinic, Md Medical Group, Invo Bioscience, New Hope Fertility Center, Carolinas Fertility Institute, Newlife Fertility Centre, Dallas Fort Worth Fertility Associates, Overlake Reproductive Health, Fertility Center Of Las Vegas, Weill Cornell Medicine - Center For Reproductive Medicine, UCSF Center For Reproductive Health, Brigham And Women's Hospital Center For Infertility And Reproductive Surgery, Columbia University Fertility Center, Duke Fertility Center, Advanced Fertility Center Of Texas, Cleveland Clinic Fertility Center, NYU Langone Fertility Center, Mayo Clinic Assisted Reproductive Technologies Rochester, Massachusetts General Hospital Fertility Center, IVF Canada, Bio Fertility Center, The Mexican Institute For Higher Reproductive Technology (Inmater), Select IVF, Fertility Patagonia, In Vitro Buenos Aires, Halitus Instituto Medico, Pregna Medicina Reproductiva, IVF Panama Centro De Reproduccion Punta Pacifica, Colombian Center For Fertility, Sterility, Carrot Fertility, Oya Care, Kitazato, Dubai Fertility Center, Fakih IVF Fertility Center, Orchid Fertility, Bourn Hall Fertility Clinic, Alboshra IVF Center, George's Memorial Medical Centre, Nordica Fertility Centre, The Olive Branch Clinic, St. Ives Specialist Hospital, Bridge Clinic Fertility Centre, Cairo Fertility Centre, Queens Fertility Centre, BPE Partners, Cleopatra Hospitals Group

Western Europe was the largest region in the fertility services market in 2024. North America was the second largest region in global fertility services market share. The regions covered in the fertility services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fertility services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The fertility services market includes revenues earned by entities by providing artificial insemination, and intrauterine insemination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fertility Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fertility services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for fertility services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fertility services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Fertility Services Market Characteristics

3. Fertility Services Market Trends And Strategies

4. Fertility Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Fertility Services Growth Analysis And Strategic Analysis Framework

6. Fertility Services Market Segmentation

7. Fertility Services Market Regional And Country Analysis

8. Asia-Pacific Fertility Services Market

9. China Fertility Services Market

10. India Fertility Services Market

11. Japan Fertility Services Market

12. Australia Fertility Services Market

13. Indonesia Fertility Services Market

14. South Korea Fertility Services Market

15. Western Europe Fertility Services Market

16. UK Fertility Services Market

17. Germany Fertility Services Market

18. France Fertility Services Market

19. Italy Fertility Services Market

20. Spain Fertility Services Market

21. Eastern Europe Fertility Services Market

22. Russia Fertility Services Market

23. North America Fertility Services Market

24. USA Fertility Services Market

25. Canada Fertility Services Market

26. South America Fertility Services Market

27. Brazil Fertility Services Market

28. Middle East Fertility Services Market

29. Africa Fertility Services Market

30. Fertility Services Market Competitive Landscape And Company Profiles

31. Fertility Services Market Other Major And Innovative Companies

32. Global Fertility Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fertility Services Market

34. Recent Developments In The Fertility Services Market

35. Fertility Services Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기